Anti-Microbial Savior BioteQ Co., Ltd. (TPEX:6864)
Taiwan
· Delayed Price · Currency is TWD 52.00
+0.50 (0.97%)
Mar 10, 2026, 1:46 PM CST
TPEX:6864 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Cash & Equivalents | 194.13 | 78.43 | 131.11 | 166.58 | 92.36 | Upgrade
|
| Cash & Short-Term Investments | 194.13 | 78.43 | 131.11 | 166.58 | 92.36 | Upgrade
|
| Cash Growth | 147.53% | -40.18% | -21.29% | 80.36% | 204.62% | Upgrade
|
| Accounts Receivable | - | - | - | 0.07 | - | Upgrade
|
| Other Receivables | 0.54 | 0.43 | 0.1 | - | 0.06 | Upgrade
|
| Receivables | 0.54 | 0.43 | 0.1 | 0.07 | 0.06 | Upgrade
|
| Inventory | 2.18 | 0.51 | 0.33 | 0.84 | - | Upgrade
|
| Prepaid Expenses | 6.02 | 4.13 | 2.15 | 1.51 | 1.11 | Upgrade
|
| Total Current Assets | 202.86 | 83.49 | 133.69 | 169 | 93.53 | Upgrade
|
| Property, Plant & Equipment | 21.41 | 20.34 | 28.83 | 41.91 | 44.56 | Upgrade
|
| Long-Term Investments | - | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Long-Term Deferred Tax Assets | 22.22 | 22.22 | 17.21 | 8.44 | 3.48 | Upgrade
|
| Other Long-Term Assets | 1.69 | 1.99 | 2.23 | 1.81 | 1.12 | Upgrade
|
| Total Assets | 248.18 | 128.05 | 181.96 | 221.16 | 142.71 | Upgrade
|
| Accounts Payable | - | 0.27 | 0.27 | 0.93 | - | Upgrade
|
| Current Portion of Leases | 2.19 | 1.38 | 2.6 | 1.46 | 1 | Upgrade
|
| Current Income Taxes Payable | - | - | 0.7 | - | - | Upgrade
|
| Current Unearned Revenue | 0.19 | 0.13 | - | - | - | Upgrade
|
| Other Current Liabilities | 8.29 | 5.21 | 4.81 | 2.99 | 2.35 | Upgrade
|
| Total Current Liabilities | 10.67 | 6.99 | 8.39 | 5.38 | 3.35 | Upgrade
|
| Long-Term Debt | - | - | - | 9.17 | - | Upgrade
|
| Long-Term Leases | 0.19 | - | 1.38 | 2.68 | 3.08 | Upgrade
|
| Total Liabilities | 10.87 | 6.99 | 9.77 | 17.23 | 6.42 | Upgrade
|
| Common Stock | 323.45 | 250 | 250 | 250 | 160 | Upgrade
|
| Additional Paid-In Capital | 117.97 | 0.64 | - | - | - | Upgrade
|
| Retained Earnings | -204.1 | -129.59 | -77.81 | -46.07 | -23.72 | Upgrade
|
| Shareholders' Equity | 237.31 | 121.05 | 172.2 | 203.93 | 136.28 | Upgrade
|
| Total Liabilities & Equity | 248.18 | 128.05 | 181.96 | 221.16 | 142.71 | Upgrade
|
| Total Debt | 2.39 | 1.38 | 3.99 | 13.31 | 4.07 | Upgrade
|
| Net Cash (Debt) | 191.74 | 77.04 | 127.13 | 153.27 | 88.29 | Upgrade
|
| Net Cash Growth | 148.87% | -39.40% | -17.06% | 73.60% | 249.40% | Upgrade
|
| Net Cash Per Share | 6.33 | 3.08 | 5.09 | 8.16 | 10.36 | Upgrade
|
| Filing Date Shares Outstanding | 32.28 | 24.99 | 24.99 | 21.61 | 9.06 | Upgrade
|
| Total Common Shares Outstanding | 32.28 | 24.99 | 24.99 | 21.61 | 9.06 | Upgrade
|
| Working Capital | 192.19 | 76.5 | 125.31 | 163.62 | 90.18 | Upgrade
|
| Book Value Per Share | 7.35 | 4.84 | 6.89 | 9.44 | 15.04 | Upgrade
|
| Tangible Book Value | 237.31 | 121.05 | 172.2 | 203.93 | 136.28 | Upgrade
|
| Tangible Book Value Per Share | 7.35 | 4.84 | 6.89 | 9.44 | 15.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.